Universal Health Services, Inc. (UHS)
NYSE: UHS · Real-Time Price · USD
199.88
0.00 (0.00%)
Jan 16, 2026, 4:00 PM EST - Market closed
Universal Health Services Market Cap
Universal Health Services has a market cap or net worth of $12.49 billion as of January 20, 2026. Its market cap has increased by 5.52% in one year.
Market Cap
12.49B
Enterprise Value
17.49B
1-Year Change
5.52%
Ranking
Category
Stock Price
$199.88
Market Cap Chart
Since December 1, 1998, Universal Health Services's market cap has increased from $1.76B to $12.49B, an increase of 607.87%. That is a compound annual growth rate of 7.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 12.49B | -8.32% |
| Dec 31, 2025 | 13.62B | 15.10% |
| Dec 31, 2024 | 11.84B | 13.74% |
| Dec 29, 2023 | 10.41B | 3.42% |
| Dec 30, 2022 | 10.06B | -3.46% |
| Dec 31, 2021 | 10.42B | -10.81% |
| Dec 31, 2020 | 11.69B | -7.00% |
| Dec 31, 2019 | 12.56B | 16.52% |
| Dec 31, 2018 | 10.78B | 0.23% |
| Dec 29, 2017 | 10.76B | 4.31% |
| Dec 30, 2016 | 10.31B | -12.35% |
| Dec 31, 2015 | 11.77B | 6.86% |
| Dec 31, 2014 | 11.01B | 37.89% |
| Dec 31, 2013 | 7.99B | 69.91% |
| Dec 31, 2012 | 4.70B | 25.28% |
| Dec 30, 2011 | 3.75B | -11.17% |
| Dec 31, 2010 | 4.22B | 40.72% |
| Dec 31, 2009 | 3.00B | 57.68% |
| Dec 31, 2008 | 1.90B | -30.77% |
| Dec 31, 2007 | 2.75B | -8.60% |
| Dec 29, 2006 | 3.01B | 17.92% |
| Dec 30, 2005 | 2.55B | -1.74% |
| Dec 31, 2004 | 2.60B | -16.65% |
| Dec 31, 2003 | 3.11B | 14.07% |
| Dec 31, 2002 | 2.73B | 6.58% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |